Xerese (acyclovir/hydrocortisone cream) has been made available by Meda for the treatment of recurrent herpes simplex labialis (cold sores). Xerese is formulated with 5% acyclovir and 1% hydrocortisone. In clinical trials, Xerese demonstrated greater efficacy versus 5% acyclovir in the same cream vehicle (with early treatment) and reduced the likelihood of progression to ulceration with early treatment.

For more information call (732) 564-2200 or visit www.xerese.com.